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Available online 13 July 2004Although multivariate analytic techniques might identify diagnostic
patterns that are not captured by univariate methods, they have rarely
been used to study the neural correlates of Alzheimer’s disease (AD) or
cognitive impairment. Nonquantitative H2
15O PET scans were acquired
during rest in 17 probable AD subjects selected for mild severity
[mean-modified Mini Mental Status Examination (mMMS) 46/57; SD
5.1], 16 control subjects (mMMS 54; SD 2.5) and 23 subjects with
minimal to mild cognitive impairment but no dementia (mMMS 53; SD
2.8). Expert clinical reading had low success in discriminating AD and
controls. There were no significant mean flow differences among
groups in traditional univariate SPM Voxel-wise analyses or region of
interest (ROI) analyses. A covariance pattern was identified whose
mean expression was significantly higher in the AD as compared to
controls ( P = 0.03; sensitivity 76–94%; specificity 63–81%). Sites of
increased concomitant flow included insula, cuneus, pulvinar, lingual,
fusiform, superior occipital and parahippocampal gyri, whereas
decreased concomitant flow was found in cingulate, inferior parietal
lobule, middle and inferior frontal, supramarginal and precentral gyri.
The covariance analysis-derived pattern was then prospectively applied
to the cognitively impaired subjects: as compared to subjects with
Clinical Dementia Rating (CDR) = 0, subjects with CDR = 0.5 had
significantly higher mean covariance pattern expression ( P = 0.009).
Expression of this pattern correlated inversely with Selective Remind-
ing Test total recall (r = 0.401, P = 0.002), delayed recall (r = 0.351,
P = 0.008) and mMMS scores (r = 0.401, P = 0.002) in all three groups
combined. We conclude that patients with AD may differentially
express resting cerebral blood flow covariance patterns even at very
early disease stages. Significant alterations in expression of resting flow
covariance patterns occur even for subjects with cognitive impairment.
Expression of covariance patterns correlates with cognitive and1053-8119/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.neuroimage.2004.04.032
* Corresponding author. Sergievsky Center, Columbia Presbyterian
Medical Center, PH 19th floor, 622 West 168th street, New York, NY,
10032. Fax: +1-212-3421838.
E-mail address: ns257@columbia.edu (N. Scarmeas).
Available online on ScienceDirect (www.sciencedirect.com.)functional performance measures, holding promise for meaningful
associations with underlying biopathological processes.
D 2004 Elsevier Inc. All rights reserved.
Keywords: Cognitive; Alzheimer’s disease; Covariance; MCI; PET; CBF,
diagnosisIntroduction
Regional cerebral blood flow (rCBF) or regional cerebral
glucose metabolism (rCMRglc) deficits have been documented in
patients with Alzheimer’s disease (AD) either via expert clinical
reading (Hoffman et al., 2000; Silverman et al., 2001) or statistical
methods (usually region of interest analyses or more rarely voxel-
wise analyses, Ishii et al., 1997; Kennedy et al., 1995; Minoshima
et al., 1997; Salmon et al., 2000; Signorini et al., 1999). Both rCBF
and rCMRglc are reliable indices of neuronal/synaptic function
(Jueptner and Weiller, 1995) and are considered to provide a
valuable in vivo index of the effects of the neuropathological
process on brain function in patients with AD. This is supported by
the fact that that reductions in rCBF or rCMRglc have been
reported to co-localize with areas where AD-related neuropatho-
logical changes occur (i.e. posterior cingulate, temporal-parietal-
occipital and, later in the disease, frontal association areas)
(DeCarli et al., 1992; Friedland et al., 1985; Hoffman et al.,
2000; McGeer et al., 1986a,b, 1990a,b; Mielke et al., 1996). Also,
regions that are spared by AD pathology until later on in the
disease (perirolandic cortex, primary visual cortex, deep structures
such as basal ganglia, thalamus and cerebellum) usually manifest
normal rCBF or rCMRglc (Arnold et al., 1991; DeCarli et al.,
1992; Hoffman et al., 2000; Smith et al., 1992). Therefore, one of
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loss of neurons and in turn decrease in the local flow and metabolic
demands. Because AD is often characterized by accumulation of h
amyloid not only in the parenchyma but also in the vascular
compartments, amyloid-dependent alterations in the vessel wall
and resulting changes in cerebrovascular reactivity have been
proposed as another possible explanation of rCBF reductions in
AD (Gsell et al., 2000).
Since AD pathology starts from medial temporal regions (Braak
and Braak, 1991), which constitute a major source of projections to
medial parietal/posterior cingulate areas, it has been also hypothe-
sized that decreased flow in parietal association areas or cingulate
may be a distant effect of disruption of such projections (Aupee et
al., 2001;Meguro et al., 1999;Millien et al., 2002; Vogt et al., 1992).
Intrinsic cholinergic neurons of the basal forebrain (substantia
innominata and nucleus basalis of Meynert) project to cortical areas
and participate in the regulation of rCBF. Because the cholinergic
system of the basal forebrain, including its areas of projection to
hippocampus and neocortex, are disrupted in AD, a distant effect of
cholinergic dysregulation has also been proposed as one of the
possible mechanisms for reduced rCBF in AD (Gsell et al., 2000).
In addition to anatomically localized rCBF or rCMRglc
changes, alterations in the way flow or metabolism covaries across
brain areas may also occur (Grady et al., 2001). Neuropathological
processes may impose a reorganization of the functional connec-
tivity between brain areas. Because cognitive processes are the
result of integrated activity in networks of areas rather than activity
of any one area in isolation (Alexander and Moeller, 1994; Friston,
1994; Friston et al., 1993; Horwitz et al., 1995b; McIntosh and
Gonzalez-Lima, 1994), functional connectivity can be better cap-
tured by multivariate methods.
How could connectivity at rest be conceived or interpreted?
First, it is known that the brain continues to process and encode
information long after external stimuli have extinguished: a cas-
cade of biochemical processes remains active throughout a pro-
tracted consolidation period, which may last weeks in rodents and
months to years in primates (Kim and Fanselow, 1992; Zola-
Morgan and Squire, 1990). Therefore, rCBF changes detected at
rest may be related to mnemonic cognitive processes. In addition, it
has been hypothesized that large sections of the lateral and medial
parietal cortex (including posterior cingulate and precuneus) and
the medial frontal cortex constitute a ‘‘default network’’ supporting
processes more active during rest than activation conditions (Lustig
et al., 2003; Raichle et al., 2001). Interconnected activity of such
brain areas during rest may be serving purposes of monitoring the
environment, monitoring one’s internal state and emotions, and
various forms of undirected thought. It has been hypothesized that
engagement in cognitive tasks during activation studies may
redirect resources to task-specific processes and manifested as
consistent deactivation of regions of this ‘‘default network’’.
Although some studies have used multivariate techniques during
cognitive activation paradigms (Grady et al., 2001; Horwitz et al.,
1995a,b; Stern et al., 2000), we know of only two studies (Alexander
et al., 1994; Johnson et al., 1998) (one ofwhich only in abstract form)
which used multivariate techniques to assess changes in brain flow
or metabolism at rest in AD. In contrast, these methods have been
used in resting PETor SPECTstudies of normal aging (Moeller et al.,
1996), stroke (Leibovitch et al., 1999), epilepsy (Rubin et al., 1995),
Parkinson’s disease (Eidelberg et al., 1995a; Feigin et al., 2001a,b;
Moeller et al., 1996), subthalamotomy, pallidotomy or pallidal
stimulation in Parkinson’s disease (Eidelberg et al., 1996; Fukudaet al., 2001; Su et al., 2001), Huntington’s disease (Feigin et al.,
2001a,b), blepharospasm (Hutchinson et al., 2000) dystonia (Eidel-
berg et al., 1995b, 1998) and depression (Sackeim et al., 1990, 1993).
In a few studies that have examined rCBF or rCMRglc changes
in populations with cognitive deficits (at high risk for AD but not
yet demented) (Arnaiz et al., 2001; Berent et al., 1999; De Santi et
al., 2001; Minoshima et al., 1997; Okamura et al., 2002; Ouchi et
al., 1998; Pietrini et al., 1993), reduced rCMRglc of the hippo-
campal formation (De Santi et al., 2001; Ouchi et al., 1998) has
been reported. Reduced rCBF or rCMRglc in the temporal neo-
cortex (Arnaiz et al., 2001; Berent et al., 1999; Pietrini et al., 1993)
and posterior cingulate (Minoshima et al., 1997; Okamura et al.,
2002) has been reported to predict conversion to AD. Only one
study (Johnson et al., 1998) used multivariate techniques to
examine resting flow in questionable AD. It is conceivable that
alterations in strength of functional connectivity may differ in
subjects manifesting cognitive deficits secondary to insidious AD
neuropathology as compared to those exhibiting benign, age-
related cognitive deficits. We hypothesized that a covariance
pattern that is altered in AD patients (as compared to healthy
elderly) would also be altered in subjects with cognitive deficits but
not dementia so that it would be differentially expressed between
those with more cognitive and functional deficits (presumably due
to underlying AD) and those with less cognitive and functional
deficits (presumably due to age-related changes). We investigated
this hypothesis by: (i) applying covariance analysis to PET scans
from AD patients and healthy elderly, (ii) identifying a covariance
pattern whose expression best discriminated the two groups, (iii)
prospectively applying this derived pattern to a population with
cognitive impairment (but no dementia) and (iv) investigating the
relation between pattern expression and functional or cognitive
measures within the population with cognitive impairment.Materials and methods
Subjects and evaluation
Seventeen subjects with mild AD (11 males and 6 females), 23
with minimal to mild cognitive impairment but no dementia (CI)
(15 males and 8 females) and 16 healthy elderly subjects (8 males
and 8 females) met criteria for entry into the study. AD and CI
subjects were recruited from outpatients who presented to the
Alzheimer’s Disease Research Center at Columbia University.
AD subjects met DSM-III-R criteria for dementia and NINCDS-
ADRDA criteria for probable AD (McKhann et al., 1984). Only AD
subjects rated as Clinical Dementia Rating (CDR) = 1(Hughes et al.,
1982) were used in this study. Other causes of dementia were
excluded with appropriate laboratory tests.
The CI subjects were participating in a longitudinal study, the
details of which are described elsewhere (Devanand et al., 2000;
Tabert et al., 2002). Inclusion criteria were the following:
(i) age z40 years;
(ii) intellectual impairment as evidenced by either of the following:
(a) recall of two of three objects or fewer after 5 min on the
mean-modified Mini Mental Status Examination (mMMS)
(Stern et al., 1987) or a delayed recall score of >1 SD
below normative values on the six-trial Selective Remind-
ing Test (SRT) (Buschke and Fuld, 1974) or impaired
intellectual performance as evidenced by a Wechsler Adult
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mance IQ z10 points below the verbal IQ score.
(b) subjective complaints of a decline in memory or cognitive
functioning, as objectively identified by an informant and a
positive score on at least one of the first eight items of the
modified Blessed Functional Activity Scale (Blessed et al.,
1968).
(iii) duration of intellectual impairment for z6 months and V10
years.
(iv) The above should result in a consensus diagnosis of ‘‘non-
demented with minimal cognitive impairment’’ (CDR of 0) or
‘‘questionably demented’’ (CDR of 0.5) (Hughes et al., 1982).
These inclusion criteria are more inclusive as compared to those
used in other studies of mild cognitive impairment (Petersen et al.,
2001) because we intended to enroll a relatively broad group of
subjects who presented with cognitive complaints and fell between
the ‘‘normal’’ and ‘‘dementia’’ categories, whose cognitive deficits
were ranging from minimal to mild severity. Based on a compre-
hensive review of all available clinical and diagnostic information,
a consensus diagnosis by expert raters determined CDR status and
study entry (Devanand et al., 2000).
The AD patients and the CI subjects underwent extensive
neuropsychological evaluation including the WAIS-R (Wechsler,
1981); themMMS (Stern et al., 1987); tests of verbal memory (short-
and long-term verbal, (Buschke and Fuld, 1974); and nonverbal,
(Benton, 1955; Buschke and Fuld, 1974)); orientation; abstract
reasoning (verbal, (Wechsler, 1981); and nonverbal, (Mattis,
1976)); language (naming, (Kaplan et al., 1983); verbal fluency,
(Benton and Hamsher, 1976; Goodglass and Kaplan, 1983); com-
prehension, (Goodglass and Kaplan, 1983); and repetition, (Good-
glass and Kaplan, 1983)); and construction copying (Rosen, 1983);
and matching, (Benton, 1955). The Blessed Dementia Rating Scale
(part I, sections A and B) (Blessed et al., 1968) was administered to
assess basic and instrumental activities of daily living.
Based on a comprehensive review of all available information,
a consensus diagnostic conference of neurologists, psychiatrists
and neuropsychologists determined the diagnosis of AD or CI,
CDR status and study entry. PET results did not play any role in the
diagnostic process.
Potential healthy elderly subjects were carefully screened with
medical, neurological, psychiatric and neuropsychological evalua-
tions (mMMS, (Stern et al., 1987); the American version of the
Nelson Adult Reading Test estimated IQ, (Nelson and O’Connell,
1978); the WAIS-R digit symbol and vocabulary subscores,
(Wechsler, 1981); and the SRT, (Buschke and Fuld, 1974)) to
exclude those with dementia or cognitive impairment, as well as
other neurological, psychiatric or severe medical disorders.
Subjects with any active symptoms of depression (as assessed
by interviews with Neurologists and Psychiatrists) were not
included in this study. Additionally, participants of this study
were not receiving any central nervous system-acting medications
that may affect rCBF or rCMRglc. Magnetic resonance imaging
was used to rule out subjects with space occupying lesions or
vascular disease. White matter hyperintensities were permitted but
any clinical evidence (symptoms or signs) of stroke or MRI
evidence of cortical or lacunar infarcts constituted exclusion
criteria.
The pattern of subjects’ APOE isoforms was also determined
(Hixson and Powers, 1991). Due to subjects’ refusal, APOE
information was not available for 4/17 AD patients and 2/23 CIsubjects. For the purpose of the analysis, subjects were categorized
into three groups, those with two epsilon four alleles (q4/q4), those
with one(q3/q4 or q2/q4) and those without any (q3/q3 or q2/q2
or q3/q2).
Informed consent was obtained after the nature and risks of the
study were explained. Only cross-sectional data are used for the
purposes of the current analysis.
PET scan acquisition and processing
H2
15O resting PET scans were acquired. A bolus of 30 mCi
H2
15O was injected intravenously. Scan acquisition was triggered
by the detection of a threshold level of true counts from the
camera. Employing a Siemens EXACT 47 PET camera (Knox-
ville, TN, USA), two 30-s scan frames were acquired in two-
dimensional mode, which were subsequently averaged to yield a
single image per subject. After measured attenuation correction
(15-min transmission scan) and reconstruction by filtered back-
projection, image resolution was 4.6 mm full width at half-
maximum (FWHM). Arterial blood sampling was not conducted;
thus, only nonquantitative count images (and not absolute rCBF
measures) could be obtained. The image of each subject was
spatially transformed to the PET Montreal Neurological Institute
brain space template included with SPM99 program (Wellcome
Department of Neurology). The spatially transformed images
were smoothed with an isotropic, Gaussian kernel (FWHM =
12 mm).
Clinical readings
AD–control group discrimination was first attempted via expert
clinical reading of PET scans by a dementia neurologist specialist
with 10 years of experience in brain SPECT and PET evaluation
who was blinded to all clinical information. A dichotomous rating
for the presence or absence of the classic AD-related temporo-
parietal-frontal hypometabolism pattern with sparing of cerebel-
lum, basal ganglia and sensorimotor cortex was generated. This
was followed by a rating of high and low levels of confidence in
the presence of the normal or AD pattern.
Univariate analyses
Voxel-wise analyses
The realigned, spatially transformed and smoothed PET
image were intensity normalized by its average perirolandic
count value. When arterial blood is not sampled, some sort of
intensity normalization is typically performed (Arndt et al., 1996;
Friston et al., 1990) to reduce the inter-subject and inter-session
noise associated with qualitative PET. We used the average
rCBF values of a region of interest corresponding to primary
sensorimotor cortex as the intensity normalization factor because
this region is typically spared in AD. To effect this, a single
perirolandic region of interest, constant for all subjects, was
defined on the MNI template brain (using MEDX; Sensor
Systems, Inc, Sterling, VA). In each subject, the average PET
count value in this region of interest was determined in the
spatially normalized PET image (before spatial smoothing). This
value was used to divide the image values of the PET image of
that subject. We reasoned that intensity normalization should
reduce inter-subject scaling noise without ‘‘washing out’’ spa-
tially coherent effects of AD pathology. Confirmatory SPM
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to the global mean (the more traditional method of intensity
normalization).
After normalization, voxel-wise t statistics for between group
(AD vs. controls, AD vs. CI and CI vs. controls) comparisons were
computed using procedures in SPM99. The false positive rate was
controlled at acorrected = 0.05 per map via Bonferroni correction for
the number of resolution elements (RESELS) across which regres-
sions were calculated. Montreal Neurological Institute coordinates
of local maxima of thresholded (acorrected = 0.05) SPM maps were
converted to standard Talairach brain atlas (Talairach and Tour-
noux, 1988) coordinates (via program by Matthew Brett http://
www. mrccbu.cam.ac.uk/Imaging/mnispace.html). Using proce-
dures in SPM99 and height thresholds corresponding to uncorrect-
ed P values of 0.001, comparisons on a cluster level were also
performed.
Region of interest (ROI) analyses
MEDX (Sensor Systems, Inc) software was used to overlay a
standardized three-dimensional ROI template on the scan slices.
This template was drawn on the SPM96 standard MRI (which
conforms to Tailarach space) and defined 45 ROIs, comprising
major cortical and subcortical regions. The average rCBF values of
the ROI corresponding to primary sensory cortex (because this
region is typically spared in AD) were used for scaling. Additional
confirmatory ROI analyses conducted with images proportionally
scaled to the cerebellum ROIs or the global mean ROI values were
also performed. After normalization, t statistics for between-group
(AD vs. controls) comparisons of ROI rCBF values were com-
puted. The false positive rate was controlled at acorrected = 0.05 via
Bonferroni correction (i.e. 45 comparisons).
Covariance analysis
Covariance analysis techniques are considered appropriate
methods to explore network activity (McIntosh et al., 1996; Poline
et al., 1997). We used the Scaled Subprofile Model (SSM), a type
of analysis methodologically similar to other current covariance
analyses techniques. SSM is a form of principal component
analysis that employs the construct of ‘‘networks or patterns of
localized physiological activity’’ to capture the multidimensional
nature of functional activity at individual brain locations (Alexan-
der and Moeller, 1994; Moeller et al., 1987). This method has been
used previously in resting imaging studies of normal aging and a
variety of diseases (Eidelberg et al., 1995a,b, 1996, 1998; Feigin et
al., 2001a,b; Feigin et al., 2001a,b; Hutchinson et al., 2000;
Moeller et al., 1996; Rubin et al., 1995; Sackeim et al., 1990,
1993; Stern et al., 2000; Su et al., 2001).
The following steps were implemented:
1. Resting voxel-wise PET data from both the AD patients and
healthy elderly subjects were simultaneously included in a
single SSM analysis, which captured the major sources of
between- and within-group variation.
1.1. This analysis produced a series of principal components
(PCs). Voxels participating in each PC may have either a
positive or a negative loading. The loadings express the
covariance structure (i.e. the strength of the interaction)
between the voxels that participate in the PC. Voxels with
positive loadings can be conceived as exhibiting con-comitant increased flow and those with negative loading
can be conceived as exhibiting concomitant decreased
flow. These loadings are fixed and the same for all
subjects.
1.2. The expression of each PC for each subject was quantified
by a subject scaling factor (SSF). A higher SSF value
indicates more prominent concomitantly increased flow of
the voxels with positive loadings and more prominent
concomitantly decreased flow of the voxels with negative
loadings. Therefore, the SSFs express the degree of
subjects’ expression of the fixed PC.
2. To identify a covariance pattern that best discriminated AD
patients from controls, each subject’s expression (SSF) of the
first four PCs derived from step 1 (capturing 31% of the
variance) was entered into a linear regression model as the
independent variable. Group membership (AD vs. controls)
was the dependent variable. This regression resulted in a linear
combination of the four PCs that best discriminated the two
groups. When we use the term ‘pattern’ or ‘network’ in this
manuscript, we refer to this linear combination of the first four
PCs.
2.1. We used Akaike’s information criterion (Burnham and
Anderson, 2002) to determine how many PCs should be
included in the regression to achieve optimal bias–variance
trade. The first four PCs had the lowest value in Akaike’s
information criterion and were selected as predictors in the
regression model.
2.2. The stability and robustness of weights of all voxels of the
pattern were assessed via a bootstrap resampling technique
(Efron and Tibshirani, 1994). Bootstrap resampling iden-
tifies areas that participate in the pattern with high
confidence.
2.3. Local maxima of SPM maps were converted to standard
Talairach brain atlas (Talairach and Tournoux, 1988)
coordinates and labeled as described above.
3. The pattern derived in step 2 was then prospectively applied to
the PET data from the CI population (which was not used for
the original derivation of the pattern). The operation of forward
application is represented mathematically by a ‘‘dot’’ product:
every voxel value in a subject scan is multiplied by the cor-
responding voxel weight in the covariance pattern, with a
subsequent summation over the whole brain volume. The
resulting single number captures to what extent a subject
manifests the covariance patterns that was forward applied.
Using this procedure, each CI subject’s SSF of the pattern was
calculated.
4. Each CI subject’s SSF of the pattern was entered into a linear
regression model as the independent variable, with CDR group
membership (CDR = 0 vs. CDR = 0.5) as the dependent
variable.
5. We also evaluated the correlation between SSFs for the pattern
and demographic and neuropsychological performance indices.
This was done across groups and in each group separately.
Results
Demographic, clinical and neuropsychological data for each
of the three groups are presented in Table 1. Gender (34 males
Table 1
Demographic, clinical and neuropsychological data for the all three groups
Controls
(N = 16)
CI CDR = 0
(N = 14)
CI CDR = 0.5
(N = 9)
AD (N = 17) P value
ANOVA
omnibus
P value post hoc Tukey HSD
Age 71.4 (6.8) 64.7 (9.8) 73.6 (6.3) 68.4 (8.7) 0.054 –
Education (years) 14.9 (4.2) 16.5 (2.3) 17.2 (1.9) 15.5 (3.1) 0.288 –
mMMS [0–57] 54.1 (2.5) 55.3 (1.6) 50.8 (1.8) 46.4 (5.1) 0.000 AD–CI CDR 0.5: 0.010
AD–CI CDR 0: 0.000
AD–Controls: 0.000
CI CDR 0.5–CI CDR 0: 0.012
SRT total recall 46.5 (7.8) 52.9 (5.7) 40.0 (5.5) 28.8 (9.8) 0.000 AD–CI CDR 0.5: 0.005
AD–CI CDR 0: 0.000
AD–Controls: 0.000
CI CDR 0.5–CI CDR 0: 0.002
SRT delayed recall 7 (3.2) 8.7 (2.6) 3.9 (2.0) 2.0 (2.2) 0.000 AD–CI CDR 0: 0.000
AD–Controls: 0.000
CI CDR 0.5–CI CDR 0: 0.002
CI CDR 0.5–Controls: 0.033
Digit symbol 12.5 (2.3) 13.6 (3.2) 10.9 (2.1) 9.7 (3.5) 0.002 AD–CI CDR 0: 0.002
AD–Controls 0.031
Mean values and standard deviations (in parentheses) are reported. Initial P values are calculated with one-way ANOVA. Significant P values derived from post
hoc Tukey HSD analyses are also reported.
Fig. 1. Three-dimensional brain rendering representation of statistical
parametric map of the ‘AD–control pattern’.
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CDR = 0 subjects were slightly younger than CI CDR = 0.5.
Education did not differ across groups. Neuropsychological
performance in the AD patients was significantly lower than
that of controls or CI CDR = 0 groups for all tests. CI CDR =
0.5 subjects performed significantly better than AD patients on
the mMMS and SRT total recall, while their performance on
SRT delayed recall and digit symbol tests was comparable to the
AD patients. CI subjects with CDR = 0.5 performed worse than
CI CDR = 0 on mMMS and all SRT measures, and worse than
controls on SRT delayed recall.
Expert blinded clinical reading of this set of early AD
and control H2
15O PET scans had low success in classifying
group membership: sensitivity was 54% and specificity
25%.
The univariate voxel-wise comparisons did not reveal any
between-group differences (irrespective of whether images were
proportionally scaled to perirolandic cortex or global mean). The
groups did not differ on the cluster-level comparisons either.
These was true for AD–control, AD–CI and CI–control
comparisons.
In the univariate ROI analyses, rCBF in the left inferior
parietal ROI was significantly lower in the AD patients as
compared to controls (P = 0.04). Left posterior cingulate ROI
(P = 0.08) and left hippocampus ROI (P = 0.10) had also
somehow lower rCBF for the AD patients. However, after
controlling for the false positive rate, the differences were not
significant for any of the regions. Additional confirmatory ROI
analyses conducted with images proportionally scaled to the
cerebellum ROIs or the global mean ROI values did not produce
any different results.
The pattern identified with the multivariate method is
presented in Fig. 1. Positive loadings (concomitant increased
flow) were noted in bilateral insula, lingual gyri and cuneus;
left fusiform and superior occipital gyri; and right parahippo-
campal gyrus and pulvinar (Table 2). Negative loadings (con-
comitant decreased flow) were noted in bilateral inferiorparietal lobule and cingulate; and left middle frontal, inferior
frontal, precentral and supramarginal gyri (Table 3).
Mean expression of the pattern was higher in the AD group
than in the healthy elderly (P = 0.03) (Fig. 2A). Thus, compared
to the healthy elders, AD subjects had more concomitantly
increased flow at areas with positive loading and more prominent
concomitantly decreased flow at areas with negative loadings. An
ROC curve was used to determine an SSF cutoff that produced
optimal sensitivity and specificity. At a SSF cutoff of 19.5, the
pattern was 76% sensitive and 81% specific for discriminating
AD vs. control. At a cutoff of 15.7, sensitivity was 94% and
specificity 63%. When age was included as covariate the results
were unchanged.
When the pattern derived from the control and AD group was
prospectively applied to the CI group, expression of the pattern
was higher in the 9 CI subjects with CDR = 0.5 as compared to
Table 2
Talairach coordinates of areas in discriminatory covariance pattern with
positive loadings
X Y Z Location Brodmann
area
36 11 4 right insula 13
48 55 14 left fusiform gyrus 37
16 74 1 left lingual gyrus 18
24 70 5 left lingual gyrus 19
14 74 6 left cuneus 18
12 37 2 right parahippocampal gyrus 30
8 31 0 right pulvinar –
32 5 9 left insula –
0 84 32 left cuneus 19
12 88 27 right cuneus 19
16 70 7 right lingual gyrus 18
34 84 28 left superior occipital gyrus 19
The areas are presented in order of decreasing but still fulfilling significance
criterion for bootstrap (ICV > 2, P < 0.03) contribution to the pattern.
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subjects with greater functional deficits expressed the pattern
more like the AD group, while those CI subjects without
functional deficits expressed the pattern more like the healthy
elderly control group. Because of slight age difference between
the two CI groups, we controlled for age in a supplementary
analysis: the results were unchanged.
Table 4 presents correlations of expression of the pattern
(each subject’s SSF) with demographic and behavioral variables
within each of the three groups and for all subjects combined.
Expression of the pattern did not correlate with age, sex,
education or APOE status. Expression of the pattern correlated
negatively with SRT total recall score and mMMS in the CI
group (Table 4 and Fig. 2B). When all subjects were pooled,
there was also a negative correlation between pattern expression
and SRT total recall, delayed recall and mMMS scores. These
results are in accordance with the increasing mean pattern
expression in the four subject groups (controls < CI-CDR = 0
< CI-CDR = 0.5 < AD): expression increased with the severity of
functional deficit (Fig. 2A). Thus, increasing expression of theTable 3
Talairach coordinates of areas in discriminatory covariance pattern with
negative loadings
X Y Z Location Brodmann
area
8 14 38 cingulate 24
2 55 27 cingulate 31
40 12 36 left middle frontal gyrus 9
46 11 27 left inferior frontal gyrus 9
36 23 34 left precentral gyrus 9
32 28 18 left inferior frontal gyrus 47
48 53 28 left supramarginal gyrus 40
32 41 43 left inferior parietal lobule 40
44 12 39 left precentral gyrus 4
4 37 30 cingulate 31
6 41 26 cingulate 23
34 37 41 right inferior parietal lobule 40
The areas are presented in order of decreasing but still fulfilling significance
criterion for bootstrap (ICV < 2, P < 0.03) contribution to the pattern.
Fig. 2. (A) Expression of the pattern in the controls and AD patients, and
expression derived from prospective application of the pattern to CI with
CDR = 0 and CI with CDR = 0.5. Note the gradual increase in pattern
expression in groups with gradually increasing functional impairment. (B)
Expression of the pattern plotted against mMMS score and SRT total recall
score for the CI group only (correlation coefficients and significance values
are presented in Table 4). Although the pattern is derived from the AD and
control population, note the association between its expression and
cognitive performance measures when prospectively applied in the CI
group.
Table 4
Pearson correlation coefficients (r) between expressions of the pattern (each subject’s SSF) and demographic and behavioral variables within each of the three
groups and for all subjects combined
Controls (N = 16) CI (N = 23) AD (N = 17) All subjects (N = 56)
Age 0.106 (0.697) 0.372 (0.081) 0.197 (0.449) 0.035 (0.797)
Gender 0.010 (0.970) 0.157 (0.475) 0.337 (0.186) 0.020 (0.887)
Education (years) 0.050 (0.853) 0.244 (0.262) 0.413 (0.099) 0.240 (0.074)
APOE genotype* 0.197 (0.465) 0.032 (0.891) 0.423 (0.150) 0.171 (0.236)
mMMS [0–57] 0.188 (0.485) 0.502 (0.015) 0.362 (0.153) 0.401 (0.002)
Selective Reminding Test total recall 0.266 (0.320) 0.444 (0.034) 0.337 (0.185) 0.401 (0.002)
Selective Reminding Test delayed recall 0.276 (0.301) 0.304 (0.158) 0.165 (0.526) 0.351 (0.008)
Digit symbol (age adjusted) 0.129 (0.634) 0.004 (0.987) 0.303 (0.254) 0.231 (0.090)
P values are reported in parentheses. Significant correlation coefficients are reported in bold format.
*APOE information was available for all 16/16 Controls, 21/23 CI subjects and 13/17 AD patients (50/56 subjects overall).
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performance (Table 4).Discussion
Expert clinical reading and univariate analyses could not
discriminate resting scans of mild AD patients and controls.
However, expression of a PET covariance pattern was significantly
altered in the AD patients (as compared to controls). When this
pattern was prospectively applied to a CI population, its expression
significantly differed among CI subjects with and without func-
tional deficits. Those with more deficits expressed the pattern more
like AD patients. Expression of this pattern also correlated with
neuropsychological performance.
AD–control discrimination
FDG PET clinical reading using AD subjects with all levels of
clinical severity has an approximate sensitivity of 93% with spec-
ificity of 63–76% (Hoffman et al., 2000; Silverman et al., 2001). In
the literature of voxel-wise analyses, reduced rCBF in temporal,
parietal and cingulate cortex has been noted in AD patients in
comparison to controls (Ishii et al., 1997; Kennedy et al., 1995;
Minoshima et al., 1997; Salmon et al., 2000; Signorini et al., 1999).
With the exception of one study (Ishii et al., 1997), all other previous
reports included moderate- or even advanced-stage AD patients
(Kennedy et al., 1995; Minoshima et al., 1997; Salmon et al., 2000;
Signorini et al., 1999). It is also unclear whether all of these studies
used corrections for multiple comparisons in their statistical tests.
Because it was conceivable that voxel-wise analysis may have
resulted in low signal-to-noise ratio, we also explored our data with
ROI analyses. Overall, in this data set, the AD–control differences
were small: they did not survive the multiple comparison correc-
tion in the ROI analysis and they could not be visually identified
via expert clinical reading. Probably the most important reason for
failure of expert clinical reading or univariate analyses to demon-
strate significant differences between AD patients and controls in
the current study was the exclusive recruitment of mild AD
patients. This could have minimized rCBF changes in comparison
to controls. However, it is notable that the ROI analysis identified a
tendency for decreased rCBF at parietal, posterior cingulate and
hippocampal regions. Since these are the areas where early AD
pathological changes and rCBF reductions are usually noted, the
ROI analyses provide reassurance for the quality of the data and
the methodology used.A multivariate method that concentrated on the covariance of
rCBF across brain areas proved to be a relatively more powerful
tool with sensitivity 76–94% and specificity 63–81%. A previous
study had reported a diagnostic accuracy of 93.4% in discriminat-
ing between AD patients and controls with use of multivariate
techniques (Johnson et al., 1998). Nevertheless, there was still
considerable overlap in pattern expression among AD patients and
controls; therefore, the derived pattern cannot qualify as a suffi-
cient diagnostic test in clinical settings.
CI subjects
When the pattern that was derived from the controls and AD
patients was prospectively applied to the subjects with CI, the
degree of each subject’s expression of the pattern was different for
subjects with CDR = 0 as compared to the ones with CDR = 0.5.
Expression of the pattern in the CI group also correlated with
neuropsychological test scores. Given that CI subjects who express
the pattern to a greater degree demonstrated functional deficits and
that AD subjects expressed the pattern to an even greater degree,
we hypothesize that higher pattern expression may be an indicator
for insidious AD pathology. Without prospective follow-up, we can
only speculate that CI with higher levels of topographic expression
are at a greater risk of conversion to AD. One previous study used
multivariate techniques in analyzing brain Tc-HMPAO SPECT
data from a questionable AD population (Johnson et al., 1998).
In that study, the accuracy of discriminating 27 questionable AD
subjects who did not progress from 18 questionable AD subjects
who converted to AD over a 2-year follow-up was 84.4%. The
current study is limited to strictly cross-sectional information.
The most important advantage of the current analysis is that
the pattern was derived from the AD–control comparison and was
then prospectively applied to the CI PET data. The fact that
expression of the identified pattern correlated with functional and
cognitive measures in a population whose PET data were not used
to derive the pattern provides strong evidence for its validity and
generalizability. Our success in reproducing pattern expression in
a new population is in accordance with previous reports (Moeller
et al., 1996).
Pattern expression and cognitive measures
Although CDR ratings were derived via a consensus diagnostic
conference, they may contain subjective elements. Thus, it is
notable that pattern expression also correlated with cognitive
performance as objectively measured by neuropsychological test-
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and neuropsychological performance remained significant when
evaluated in the CI group alone (Table 4 and Fig. 2B). The
directionality of the associations was consistent with the increasing
mean pattern expression across the four groups (controls < CI-
CDR = 0 < CI-CDR = 0.5 < AD): increasing expression of the
pattern was accompanied by increasing cognitive severity of
deficit. The correlations were not significant in the control or
AD groups alone, probably because of restricted variability in
neuropsychological performance and loss of power.
Single vs. multiple covariance patterns
Our analyses derived one pattern, which was expressed by all
subjects. The correlation structure between rCBF of brain areas that
participate in this pattern is fixed and the same for all subjects.
What differed among groups (and correlated with cognitive and
functional performance) was each subject’s degree of expression of
this pattern. The degree of expression of the covariance pattern
directly addresses how flow in different brain areas is modulated as
a function of disease status, while keeping the strength of the
interaction between areas constant. This might imply that AD
pathology affected the degree of pattern expression without
destroying the covariance pattern itself. It might also be possible
to identify different patterns for controls and AD patients. This
would imply that AD pathology impaired one pattern, which was
in turn replaced with a completely different new one.
We did not explore this alternate possibility. If separate patterns
were derived (one for the AD and a different one for the control
group), their expression would relate mostly to separate within-
group variances and not directly address between-group differ-
ences. Our strategy for identification of a single pattern is a more
conservative approach. It has the advantage of a direct comparison
of the two groups along one dimension, that is, with respect to the
subject expression of one single pattern. In addition, deriving a
single pattern provides the opportunity to prospectively apply the
pattern to the CI group. The obtained levels of expression in the CI
group then has a straightforward interpretation relative to the
expression in the other two groups: for some of the CI subjects,
the degree of pattern expression is more like the AD patients and
for some others more like the controls.
Multivariate analyses of activation studies in AD
Several groups have used multivariate methods in cognitive
activation paradigms to investigate the way in which neuropatho-
logical processes may impose a reorganization of brain networks.
In one study, path analysis indicated an altered functional network
in mild AD patients (in comparison to controls) during a face-
matching task (Horwitz et al., 1995b). Another study indicated that
PET data from healthy elderly demonstrated a strong functional
linkage along a right hemisphere ventral network (including
occipital, temporal, and frontal regions), which was similar to
young subjects. However, AD patients did not use the same
functional network (Horwitz et al., 1995a) despite their ability to
perform the task with the same accuracy.
In a delayed match to sample short-term memory paradigm
administered in early AD patients and healthy elderly (Grady et al.,
2001), memory breakdown in AD was shown to be related to
functional disconnection within a distributed network that included
the prefrontal cortex and the hippocampus. In addition, a possiblecompensatory role for an amygdala-emotion related network was
suggested for the AD patients.
In another cognitive activation study, multivariate techniques
were utilized to compare brain H2
15O PET activities between early
AD and healthy elders during performance of a serial verbal
recognition task (Stern et al., 2000). While healthy elders recruited
a network involving left anterior cingulate and anterior insula, AD
patients recruited an alternative network involving left posterior
temporal cortex, calcarine cortex, posterior cingulate and the
vermis.
Multivariate analyses, resting data and biopathological
considerations
Imaging CBF changes during activation studies typically reflect
acute changes in bioelectric phenomena (action potentials and
postsynaptic potentials) (Logothetis et al., 1999) while resting flow
changes (which are tightly coupled with glucose metabolism
changes) reflect a wide range of biochemical processes including
all the molecular machinery required for normal neuronal function
(signal transduction, second messenger cascades, protein synthesis,
axonal transport, but most of all synaptic activity) (Erecinska and
Silver, 1989; Jueptner and Weiller, 1995). Multivariate techniques
have been used to explore resting imaging data in many neurolog-
ical and psychiatric conditions (Eidelberg et al., 1995a,b, 1996,
1998; Feigin et al., 2001a,b; Feigin et al., 2001a,b; Fukuda et al.,
2001; Hutchinson et al., 2000; Moeller et al., 1996; Nakamura et
al., 2001; Rubin et al., 1995; Sackeim et al., 1990, 1993; Su et al.,
2001). RCBF covariance among brain regions that participate in
the pattern may be thought of as coordinated biochemical or
synaptic activity, suggesting some sort of connectivity between
these areas.
The fact that (i) expression of the identified covariance pattern
differed between AD and controls and that (ii) higher expression of
the pattern was associated with worse memory suggests that the
degree of expression of this pattern is related to disease status.
It has been hypothesized that interconnected activity of brain
areas such as lateral and medial parietal cortex (including posterior
cingulate and precuneus) and the medial frontal cortex during rest
may be constitute a ‘‘default network’’ serving purposes of
monitoring the environment, monitoring one’s internal state and
emotions, and various forms of undirected thought (Lustig et al.,
2003; Raichle et al., 2001). Interestingly, many of these regions
that exhibit high metabolism during rest at young people show
reduced resting metabolism in elderly, and even more reduction in
AD (Herholz et al., 2002). In accordance to these observations, we
noted that, as compared to healthy elderly, AD patients had more
prominent concomitantly decreased flow in areas of this ‘‘default
network’’ [such as medial (cingulate) and lateral (supramarginal
gyrus and inferior parietal lobule) parietal].
The concomitantly decreased flow in these areas may be a
distant effect of AD-related changes of entorhinal/perirhinal
cortex. Medial temporal regions are a major source of projections
to medial parietal/posterior cingulate areas and their disruption
leads to hypometabolism in humans and animals (Aupee et al.,
2001; Meguro et al., 1999; Millien et al., 2002; Vogt et al., 1992).
Alternatively, it is also possible that we are observing the direct
effect of AD pathology itself: decreased rCBF or rCMRglc has
been reported to co-localize with areas where AD-related neuro-
pathological changes occur and is therefore considered to repre-
sent an in vivo index of the effect of the neuropathological
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and supramarginal gyrus, which are pathologically affected and
manifest decreased rCBF or rCMRglc early in AD in univariate
analyses (Hoffman et al., 2000; Ishii et al., 1997; Kennedy et al.,
1995; Minoshima et al., 1997; Silverman et al., 2001), also
showed concomitant decreased rCBF in our study. However,
medial temporal areas like the parahippocampal gyrus, which is
also pathologically affected and manifests decreased rCBF or
rCMRglc early in AD in univariate analyses, exhibited concom-
itant increased flow in our covariance pattern. Areas participating
in the covariance patterns are somehow interconnected, that is,
changes in one area affect other areas of the pattern. The presence
of the pattern even at a healthy stage suggests that cingulate–
inferior parietal lobule–supramarginal gyrus on one hand and
parahippocampal gyrus on the other are interconnected such that
they manifest concomitant flow of opposite directionality. In AD
patients the connectivity-covariance among these areas is present
(the pattern is still expressed) but it is more exaggerated in degree
(higher SSFs). It may be the case that reduced flow because of
AD pathology in certain nodes of the pattern (cingulate, inferior
parietal lobule, supramarginal gyrus) affects the whole pattern and
results in relatively increased flow in a different node (para-
hippocampal gyrus). This in accordance with a recent report
indicating increased hippocampal region rCBF (assessed by
arterial spin labeling perfusion MRI) in early AD, which gradu-
ally subsided as AD became more severe (Press et al., 2003). In
that study, up-regulation of flow in hippocampal region was
contrasted to marked rCBF decrease in neocortex and was
interpreted as a possible compensatory response in the hippo-
campal region.
Similarly, brain areas participating in covariance patterns need
not include only areas affected by neuropathology. For example,
the precentral gyrus (known to be spared by AD pathology)
participates in the observed pattern along with areas that may be
affected by the disease (like the cingulate and parietal areas).
Again, more prominent decreased flow in this area for the AD
patients may be the result of a perturbation in other nodes of the
network (i.e. AD pathology in cingulate, inferior parietal lobule
and supramarginal gyrus).
The differences in degree of pattern expression between AD
patients and controls are interesting from a biological point of
view. It suggests that some areas are interconnected in healthy
elders. When some of these areas are affected by AD pathology,
then relative concomitant flow or synaptic activity in other areas of
this network is also affected. In addition, this network perturbation
seems to occur early in the course of the disease, perhaps even
during its preclinical stages.
We sought to investigate cerebral covariance patterns in AD and
subjects with cognitive impairment using resting PET data. We
used established multivariate methods that have been shown useful
in cognitive activation imaging studies of healthy subjects, cogni-
tive activation studies of AD patients and resting imaging studies
of other neurological and psychiatric diseases. These methods
provide information about the way that brain areas covary with
each other that is not captured by traditional univariate analyses.
Although diagnostic properties of covariance patterns are still
limited for use in everyday clinical practice on a person by person
basis, alterations in expression of these patterns may be a sensitive
index of cerebral flow changes as a result of AD pathology even at
early stages. The reproduction and properties of these patterns in
our CI population suggesting meaningful associations with under-lying biopathological processes holds promise for identification of
subgroups of subjects with cognitive impairment with different
etiology and prognosis.Acknowledgments
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